Omicron variant evolution on vaccines and monoclonal antibodies-Reference-Cited by-同舟云学术

Omicron variant evolution on vaccines and monoclonal antibodies

Published:2023-05-19 Issue:4 Volume:31 Page:1779-1788
ISSN:0925-4692
Container-title:Inflammopharmacology
language:en
Short-container-title:Inflammopharmacol

Author:

Sabbatucci Michela^ORCID,Vitiello Antonio^ORCID,Clemente Salvatore,Zovi Andrea^ORCID,Boccellino Mariarosaria,Ferrara Francesco,Cimmino Carla,Langella Roberto,Ponzo Annarita,Stefanelli Paola,Rezza Giovanni

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Immunology

Link

https://link.springer.com/content/pdf/10.1007/s10787-023-01253-6.pdf

Reference52 articles.

1. Balse E, Hatem SN (2021) Do cellular entry mechanisms of SARS-Cov-2 affect myocardial cells and contribute to cardiac injury in COVID-19 patients? Front Physiol 12:630778. https://doi.org/10.3389/fphys.2021.630778

2. Callaway E (2022a) New Omicron relatives BA.4 and BA.5 offer hints about the future of SARS-CoV-2. Nature 605:204–206

3. Callaway E (2022b) What Omicron’s BA.4 and BA.5 variants mean for the pandemic. Nature 606(7916):848–849. https://doi.org/10.1038/d41586-022-01730-y

4. Cao Y, Yisimayi A, Jian F, Song W, Xiao T, Wang L, Du S, Wang J, Li Q, Chen X, Yu Y, Wang P, Zhang Z, Liu P, An R, Hao X, Wang Y, Wang J, Feng R, Sun H, Zhao L, Zhang W, Zhao D, Zheng J, Yu L, Li C, Zhang N, Wang R, Niu X, Yang S, Song X, Chai Y, Hu Y, Shi Y, Zheng L, Li Z, Gu Q, Shao F, Huang W, Jin R, Shen Z, Wang Y, Wang X, Xiao J, Xie XS (2022) BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection. Nature 608(7923):593–602. https://doi.org/10.1038/s41586-022-04980-y. (Epub 2022 Jun 17)

5. Cele S, Jackson L, Khoury DS et al (2022) Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization. Nature 602:654–656

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma (EPCORE NHL-1): a phase 2 cohort of a single-arm, multicentre study;The Lancet Haematology;2024-08

2. Therapeutic Strategies to Combat Increasing Rates of Multidrug Resistant Pathogens;Pharmaceutical Research;2024-08

3. New insights into the pathogenesis of SARS-CoV-2 during and after the COVID-19 pandemic;Frontiers in Immunology;2024-06-07

4. Neonatal and infant infection with SARS-CoV-2;Seminars in Perinatology;2024-06

5. The Impact of Antimicrobial Resistance in Cystic Fibrosis;Journal of Clinical Medicine;2024-03-16